Floatz logo

Fludarabine

Leukemia and Lymphoma

AvenCell Therapeutics, Inc.Small moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

116 Active assets in the Leukemia and Lymphoma cohort.

Asset / SponsorPhaseRating
Fludarabine
National Cancer Institute (NCI)
Phase 3BB
Pegloticase
M.D. Anderson Cancer Center
Phase 4BB
FILGRASTIM
St. Jude Children's Research Hospital
Phase 2BB
Rasburicase
M.D. Anderson Cancer Center
Phase 4BB
PREDNISONE TABLETS
M.D. Anderson Cancer Center
Phase 2BB

View all 50 →

Same molecule, other indications

Fludarabine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi anemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Adult Diffuse Large Cell LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →